A follow-up study with acoustic rhinometry in children using nasal insulin

Lotta E Haavisto1, Tero J Vahlberg, Jukka I Sipilä

  • 1Department of Otorhinolaryngology, Turku University Hospital, and Department of Biostatistics, University of Turku, Turku, Finland. lotta.haavisto@tyks.fi

Rhinology
|May 27, 2010
PubMed

Insights

Acoustic rhinometry effectively monitors children, showing no differences in nasal symptoms or nasal passage size between those receiving nasal insulin or placebo. Normal growth does not significantly impact results over two years.

Area of Science:

  • Pediatric Otolaryngology
  • Nasal Physiology
  • Diabetes Research

Background:

  • Acoustic rhinometry (AR) is a non-invasive technique for assessing nasal cavity geometry.
  • Its utility in pediatric populations, particularly concerning growth effects, requires further investigation.
  • Nasal insulin administration is explored for Type 1 Diabetes management.

Purpose of the Study:

  • To evaluate differences in rhinometric findings and nasal symptoms in children treated with nasal insulin versus placebo.
  • To assess the suitability of acoustic rhinometry for longitudinal follow-up in pediatric patients.

Main Methods:

  • A subcohort of 77 children (aged 1-12 years) from the Type I Diabetes Prediction and Prevention Study underwent acoustic rhinometry.
  • Participants received daily nasal insulin or a placebo over a two-year follow-up period.
  • Nasal symptoms, minimal cross-sectional area (MCA), and nasal volume were assessed.

Main Results:

  • No significant differences were observed in nasal symptoms, MCA, or nasal volume between the nasal insulin and placebo groups.
  • Acoustic rhinometry values showed no significant increase during the two-year follow-up period.
  • These findings suggest AR is stable in children over this timeframe, irrespective of nasal insulin treatment.

Conclusions:

  • Acoustic rhinometry is a reliable method for objective follow-up in children.
  • While AR is suitable for pediatric follow-up, normal growth factors should be considered in long-term studies.
  • Nasal insulin administration did not alter nasal cavity dimensions or symptoms in this pediatric cohort.

Related Concept Videos